Efficacy and safety of endoscopic retrograde cholangiopancreatography in recurrent pancreatitis of pediatric asparaginase-associated pancreatitis

Table 1 Preoperative data of ten children

Case	Sex	Age (yr)	Risk grading	Interval between first AAP onset and ERCP (mo)	Clinical features	Nasal jejunal tube	Number of AAP onsets (times)	Weight loss (kg)
1	Female	4	Medium	4	Abdominal pain, vomiting, inability to eat	Yes	6	2
2	Male	10	Medium	3	Abdominal pain, vomiting, inability to eat	Yes	4	6
3	Male	12	Medium	3	Abdominal pain, vomiting, inability to eat	Yes	7	7
4	Male	6	Low	6	Abdominal pain, vomiting, inability to eat	Yes	9	4
5	Female	13	Medium	3	Abdominal pain, vomiting, inability to eat	Yes	5	2
6	Male	4	Medium	3	Abdominal pain, vomiting, inability to eat	No	5	3
7	Female	4	Medium	6	Abdominal pain, vomiting, inability to eat	Yes	9	3
8	Male	7	Medium	3	Abdominal pain, inability to eat	Yes	2	7
9	Female	7	Medium	8	Abdominal pain, vomiting, inability to eat	No	9	3
10	Female	4	Medium	4	Abdominal pain, vomiting, inability to eat	No	5	3

AAP: Asparaginase-associated pancreatitis; ERCP: Endoscopic retrograde cholangiopancreatography.